Emerg Infect Dis. 2024 Jun;30(6):1203-1213. doi: 10.3201/eid3006.231553.
Major dengue epidemics throughout Nicaragua's history have been dominated by 1 of 4 dengue virus serotypes (DENV-1-4). To examine serotypes during the dengue epidemic in Nicaragua in 2022, we performed real-time genomic surveillance in-country and documented cocirculation of all 4 serotypes. We observed a shift toward co-dominance of DENV-1 and DENV-4 over previously dominant DENV-2. By analyzing 135 new full-length DENV sequences, we found that introductions underlay the resurgence: DENV-1 clustered with viruses from Ecuador in 2014 rather than those previously seen in Nicaragua; DENV-3, which last circulated locally in 2014, grouped instead with Southeast Asia strains expanding into Florida and Cuba in 2022; and new DENV-4 strains clustered within a South America lineage spreading to Florida in 2022. In contrast, DENV-2 persisted from the formerly dominant Nicaragua clade. We posit that the resurgence emerged from travel after the COVID-19 pandemic and that the resultant intensifying hyperendemicity could affect future dengue immunity and severity.
尼加拉瓜历史上的主要登革热疫情主要由 4 种登革病毒血清型(DENV-1-4)中的 1 种主导。为了研究 2022 年尼加拉瓜登革热疫情中的血清型,我们在国内进行了实时基因组监测,并记录了所有 4 种血清型的同时流行。我们观察到 DENV-1 和 DENV-4 的共同主导地位相对于以前占主导地位的 DENV-2 有所转变。通过分析 135 个新的全长 DENV 序列,我们发现新的病毒引入是疫情复发的原因:DENV-1 与 2014 年从厄瓜多尔传入的病毒聚类,而不是以前在尼加拉瓜看到的病毒;最后一次在当地传播的 DENV-3 与 2022 年扩展到佛罗里达州和古巴的东南亚毒株聚类;新的 DENV-4 株系在 2022 年传播到佛罗里达州的南美洲谱系内聚类。相比之下,DENV-2 则来自以前占主导地位的尼加拉瓜分支。我们推测,疫情的复发是由 COVID-19 大流行后的旅行引起的,由此导致的强化高度流行可能会影响未来的登革热免疫力和严重程度。